For decades, Parkinson’s disease has been framed as a simple story of dwindling dopamine, a slow erosion of the brain’s ...

A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...

A research team led by McGill University has taken a close look at a long-standing idea about Parkinson’s disease and found ...

A new study from McGill University challenges a decades-old belief about dopamine. Rather than driving movement like a ...

Explore dopamine's role in movement and how it challenges long-standing theories about motor control and Parkinson's disease ...

A novel electrode platform detects dopamine from single living brain organoids in real time, enabling non-destructive ...

This discovery challenges long standing views of dopamine’s role in neurological disorders like Parkinson’s disease, a condition that affects more than 110,000 Canadians and millions worldwide.

A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...

PHILADELPHIA — Continuous intracerebroventricular administration of an anaerobic dopamine formulation (A-dopamine) appears safe in patients with Parkinson's disease (PD) and may avoid complications ...

Regular high caffeine consumption affects dopamine function in patients with Parkinson's disease, shows a new international study led by the University of Turku and Turku University Hospital in ...

A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly ...

A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...